Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-052675
Filing Date
2025-04-10
Accepted
2025-04-10 08:02:09
Documents
1
Period of Report
2025-04-09

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3471
  Complete submission text file 0000950170-25-052675.txt   4896
Mailing Address 1 EVERTRUST PLAZA 13TH FLOOR JERSEY CITY NJ 07302-6548
Business Address 1 EVERTRUST PLAZA 13TH FLOOR JERSEY CITY NJ 07302-6548 201-884-5485
SCYNEXIS INC (Issuer) CIK: 0001178253 (see all company filings)

EIN.: 562181648 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O SCYNEXIS, INC. 3501 C TRICENTER BOULEVARD DURHAM NC 27713
Business Address
Angulo Gonzalez David (Reporting) CIK: 0001644071 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36365 | Film No.: 25826541